TNF inhibitors ‘not always’ standard of care in spondyloarthritis

SCOTTSDALE, Ariz. — Although TNF inhibitors can work “across the spectrum” in spondyloarthritis, they are “not always” the standard of care, according to a presenter at the Basic and Clinical Immunology for the Busy Clinician symposium.“Back to the original question of whether TNF is the standard of care, my answer is going to be, ‘not always’,” Lianne S. Gensler, MD, director of the SpA clinic and research program at the University of California, San Francisco, told attendees at the hybrid meeting. “First-line therapy for patientsRead More